Over the last 7 days, the Pharma industry has dropped 1.4%, driven by a pullback from Bora Pharmaceuticals of 2.9%. On the other hand Lumosa Therapeutics is actually up 5.4%. Over the past 12 months, the industry was up 3.4%. As for the next few years, earnings are expected to grow by 42% per annum.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 29 May 2024 | NT$623.8b | NT$100.4b | NT$7.1b | 29.2x | 87.3x | 6.2x |
Fri, 26 Apr 2024 | NT$622.0b | NT$101.8b | NT$9.4b | 25.4x | 66.4x | 6.1x |
Sun, 24 Mar 2024 | NT$631.3b | NT$101.1b | NT$9.5b | 26.1x | 66.8x | 6.2x |
Tue, 20 Feb 2024 | NT$609.6b | NT$101.6b | NT$8.2b | 24.1x | 74.7x | 6x |
Thu, 18 Jan 2024 | NT$574.7b | NT$101.9b | NT$7.8b | 23.8x | 73.7x | 5.6x |
Sat, 16 Dec 2023 | NT$585.4b | NT$101.6b | NT$7.6b | 24.5x | 76.8x | 5.8x |
Mon, 13 Nov 2023 | NT$563.1b | NT$101.8b | NT$9.5b | 20.6x | 59.3x | 5.5x |
Wed, 11 Oct 2023 | NT$548.3b | NT$101.7b | NT$9.6b | 21.6x | 57x | 5.4x |
Fri, 08 Sep 2023 | NT$545.2b | NT$101.7b | NT$9.6b | 22.1x | 56.7x | 5.4x |
Sun, 06 Aug 2023 | NT$574.3b | NT$98.6b | NT$10.1b | 16.7x | 57x | 5.8x |
Tue, 04 Jul 2023 | NT$598.4b | NT$98.7b | NT$10.1b | 17.2x | 59.5x | 6.1x |
Thu, 01 Jun 2023 | NT$580.4b | NT$98.0b | NT$11.0b | 18.3x | 52.8x | 5.9x |
Sat, 29 Apr 2023 | NT$569.0b | NT$92.1b | NT$8.6b | 22.5x | 65.9x | 6.2x |
Mon, 27 Mar 2023 | NT$562.0b | NT$90.6b | NT$8.1b | 20.1x | 69.7x | 6.2x |
Wed, 22 Feb 2023 | NT$558.1b | NT$84.7b | NT$7.7b | 24.2x | 72.9x | 6.6x |
Fri, 20 Jan 2023 | NT$484.3b | NT$84.6b | NT$7.9b | 20.6x | 61.4x | 5.7x |
Sun, 18 Dec 2022 | NT$489.4b | NT$84.6b | NT$7.9b | 21.3x | 62.1x | 5.8x |
Tue, 15 Nov 2022 | NT$428.4b | NT$83.2b | NT$8.0b | 15.9x | 53.5x | 5.1x |
Thu, 13 Oct 2022 | NT$428.1b | NT$78.9b | NT$4.3b | 17.1x | 98.9x | 5.4x |
Sat, 10 Sep 2022 | NT$463.4b | NT$78.9b | NT$4.3b | 18.5x | 107.1x | 5.9x |
Mon, 08 Aug 2022 | NT$382.1b | NT$76.8b | NT$4.7b | 20.7x | 80.8x | 5x |
Wed, 06 Jul 2022 | NT$379.2b | NT$76.8b | NT$4.4b | 21.2x | 86.8x | 4.9x |
Fri, 03 Jun 2022 | NT$388.3b | NT$76.8b | NT$4.4b | 20x | 88.9x | 5.1x |
Sun, 01 May 2022 | NT$388.7b | NT$76.6b | NT$6.6b | 21.2x | 59.3x | 5.1x |
Tue, 29 Mar 2022 | NT$401.8b | NT$76.4b | NT$8.8b | 20.4x | 45.9x | 5.3x |
Thu, 24 Feb 2022 | NT$410.2b | NT$76.7b | NT$8.5b | 19.4x | 48.5x | 5.3x |
Sat, 22 Jan 2022 | NT$371.5b | NT$76.7b | NT$8.5b | 18.7x | 43.9x | 4.8x |
Mon, 20 Dec 2021 | NT$391.5b | NT$76.7b | NT$8.5b | 18.1x | 46.3x | 5.1x |
Wed, 17 Nov 2021 | NT$366.5b | NT$76.8b | NT$10.3b | 16.1x | 35.7x | 4.8x |
Fri, 15 Oct 2021 | NT$354.7b | NT$76.0b | NT$10.7b | 18.5x | 33x | 4.7x |
Sun, 12 Sep 2021 | NT$357.6b | NT$76.0b | NT$10.7b | 19.3x | 33.3x | 4.7x |
Tue, 10 Aug 2021 | NT$358.7b | NT$76.0b | NT$10.7b | 21.3x | 33.4x | 4.7x |
28.3x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | 2.89% | |
Healthcare | -0.91% | |
Pharma | -0.88% | |
Pharma | -0.88% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6535 Lumosa Therapeutics | NT$194.00 | 5.4% +NT$1.6b | 218.0% | PS599.3x | |
6785 Alar Pharmaceuticals | NT$287.50 | 6.5% +NT$1.2b | 58.0% | PE46.7x | |
6634 Sinew Pharma | NT$64.20 | 12.2% +NT$498.2m | -24.3% | PB3.5x | |
6919 Caliway Biopharmaceuticals | NT$413.00 | 0.5% +NT$278.8m | 144.0% | PS1469x | |
6576 Foresee Pharmaceuticals | NT$95.90 | 1.4% +NT$176.6m | 14.6% | PS48.2x |